Tata India Pharma & Healthcare Fund
Tata Mutual Fund Β· FM: Rajat Srivastava Β· INF277K019A3 Β· Direct
NAV βΉ39.53 AUM βΉ1541 Cr as of 22 Sep 2026
Portfolio as of Jul 2026 Β· Last Update: 16-Aug-2026 05:02 PM IST
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | -0.3% | -0.6% | +4.8% | +18.8% | +9.4% | +20.9% | +14.6% | 64/234 | 1.06% |
Equity allocation
99.13%
Non-equity allocation (combined)
0.87%
All Equity Holdings (37) as of Jul 2026
| # | Company | Value (βΉ Cr) | % of AUM | Change |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LTD | 132.4 | 8.59% | β |
| 2 | DIVI LABORATORIES LTD | 98.0 | 6.36% | β |
| 3 | HEALTHCARE GLOBAL ENTERPRISES LTD | 90.2 | 5.85% | β |
| 4 | ABBOTT INDIA LTD | 86.8 | 5.63% | β |
| 5 | RAINBOW CHILDRENS MEDICARE LTD | 75.5 | 4.90% | β |
| 6 | GLAXOSMITHKLINE PHARMACEUTICALS LTD | 71.9 | 4.66% | β |
| 7 | CIPLA LTD | 69.8 | 4.53% | β |
| 8 | DR REDDYS LABORATORIES LTD | 65.5 | 4.25% | β |
| 9 | MAX HEALTHCARE INSTITUTE LTD | 62.8 | 4.07% | β |
| 10 | APOLLO HOSPITALS ENTERPRISE LTD | 60.2 | 3.90% | β |
| 11 | BAYER CROPSCIENCE LTD | 50.3 | 3.26% | β |
| 12 | FORTIS HEALTHCARE LTD | 48.1 | 3.12% | β |
| 13 | PFIZER LTD | 47.1 | 3.06% | β |
| 14 | MANKIND PHARMA LTD | 46.5 | 3.02% | β |
| 15 | SYNGENE INTERNATIONAL LTD | 45.5 | 2.95% | β |
| 16 | SAI LIFE SCIENCES LTD | 44.5 | 2.89% | β |
| 17 | LUPIN LTD | 40.8 | 2.64% | β |
| 18 | ALKEM LABORATORIES LTD | 39.7 | 2.58% | β |
| 19 | PROCTER & GAMBLE HEALTH LTD | 37.2 | 2.42% | β |
| 20 | FDC LTD | 36.8 | 2.39% | β |
| 21 | DR. LAL PATH LABS LTD | 33.5 | 2.17% | β |
| 22 | GLOBAL HEALTH LTD | 32.9 | 2.13% | β |
| 23 | CONCORD BIOTECH LTD | 29.5 | 1.91% | β |
| 24 | SUMITOMO CHEMICAL INDIA LTD | 24.5 | 1.59% | β |
| 25 | AJANTA PHARMA LTD | 23.6 | 1.53% | β |
| 26 | NEULAND LABORATORIES LTD | 19.3 | 1.25% | β |
| 27 | GILLETTE INDIA LTD | 17.8 | 1.15% | β |
| 28 | METROPOLIS HEALTHCARE LTD | 17.3 | 1.12% | β |
| 29 | MANIPAL HEALTH ENTERPRISES LTD | 15.0 | 0.97% | β |
| 30 | BASF INDIA LTD | 14.9 | 0.97% | β |
| 31 | JUBILANT PHARMOVA LTD | 12.7 | 0.83% | β |
| 32 | DR. AGARWALS HEALTH CARE LTD | 10.3 | 0.67% | β |
| 33 | SANOFI CONSUMER HEALTHCARE INDIA LTD | 8.5 | 0.55% | β |
| 34 | BIOCON LTD | 8.0 | 0.52% | β |
| 35 | ZIM LABORATORIES LTD | 7.1 | 0.46% | β |
| 36 | SANOFI INDIA LTD | 3.5 | 0.23% | β |
| 37 | ANTHEM BIOSCIENCES LTD | 0.1 | 0.01% | β |
All disclosed equity positions are shown. Non-equity allocation is the remaining portfolio weight after disclosed equities.